NEW YORK, NY / ACCESS Newswire / June 11, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading Regulatory action against Mango Markets exploiter is a win for DeFi — Moody’s.